Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 4Phase 1/2 3Phase 1 2Phase 4 1Phase 2/3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 2Lymphoid 2

Conditions

Multiple Myeloma 2Lymphoma, Follicular 2Neoplasms, Plasma Cell 1Disease 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Transplantation, Autologous × Clear all
NCT00950768 2009-08-03

Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients

Azienda Ospedaliera San Giovanni Battista

Phase 3 Completed
298 enrolled
Plasma cell

Disease, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00560053 2008-11-27

Pethema Multiple Myeloma 2000

PETHEMA Foundation

Phase 3 Completed
500 enrolled
Plasma cell

Multiple Myeloma

NCT00435955 2007-02-16

Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma

Azienda Ospedaliera San Giovanni Battista

Phase 3 Unknown
240 enrolled
Lymphoid

Lymphoma, Follicular

NCT00140569 2005-09-01

Randomized Study for Patients With Follicular Lymphoma Needing Treatment

Lymphoma Study Association

Phase 3 Completed
400 enrolled
Lymphoid

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡